Spreading gossip around the water cooler is OK, but some news just has to be shouted from the mountaintops. These days, that means it’ll be posted to our blog, Twitter feed, and Facebook status box. Researchers at the Cold Spring Harbor Laboratory, Institut des Sciences du Végétal, and Institut de Biologie Moléculaire des Plantes report […]
Ever get that feeling that you forgot something? Well maybe you did, but it doesn't have to be recent epigenetics research if you scope out our Headlines each week.
Although it may sound like the name of a DJ in a Vegas nightclub, DZNep is actually a histone methylation inhibitor, and has recently created some buzz when it was found to inhibit H3K27 and H4K20 methylation and reactivate silenced genes in cancer cells. Sensing the therapeutic possibilities, Peter Jones and his team at USC […]
It’s not news that miRNAs are out of whack in cancers. So it shouldn’t be surprising that re-expressing an oncogene-targeting miRNA might halt tumor progression. But what if the miR didn’t even have to target a specific oncogene to show off its anti-proliferative mojo? Son and father research duo (we’re pretty sure they dominated the […]
Recent advances in epigenetic therapy are promising, but their mechanisms of action and impact elsewhere in the epigenome remain a bit of a mystery. Armed with microarrays and ChIP assays, a talented team of Japanese researchers took a closer look at these approaches and found DNA methylation inhibitors and histone deacetylase (HDAC) inhibitors kill gastric […]
Promoters get all the glory when it comes to gene regulation. Sure, they’re important, but save a little love for enhancers—they may help cells decide what to be when they grow up! Historically, most methylation studies have focused on promoters, but instead of giving all the attention to these spotlight hogs, researchers at University Hospital […]